Sol Gel Technologies Stock Operating Margin
SLGL Stock | USD 12.00 0.01 0.08% |
Fundamental analysis of Sol Gel allows traders to better anticipate movements in Sol Gel's stock price by examining its financial health and performance throughout various phases of its business cycle.
Last Reported | Projected for Next Year | ||
Operating Profit Margin | (1.04) | (1.09) |
Sol | Operating Margin | Build AI portfolio with Sol Stock |
Sol Gel Technologies Company Operating Margin Analysis
Sol Gel's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Sol Gel Operating Margin | (8.80) % |
Most of Sol Gel's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sol Gel Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Sol Operating Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Sol Gel is extremely important. It helps to project a fair market value of Sol Stock properly, considering its historical fundamentals such as Operating Margin. Since Sol Gel's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sol Gel's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sol Gel's interrelated accounts and indicators.
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Sol Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Sol Gel Technologies has an Operating Margin of -8.7963%. This is 74.93% lower than that of the Pharmaceuticals sector and 92.15% lower than that of the Health Care industry. The operating margin for all United States stocks is 59.64% higher than that of the company.
Sol Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sol Gel's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sol Gel could also be used in its relative valuation, which is a method of valuing Sol Gel by comparing valuation metrics of similar companies.Sol Gel is currently under evaluation in operating margin category among its peers.
Sol Gel ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sol Gel's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sol Gel's managers, analysts, and investors.Environmental | Governance | Social |
Sol Fundamentals
Return On Equity | -0.49 | ||||
Return On Asset | -0.27 | ||||
Profit Margin | (1.08) % | ||||
Operating Margin | (8.80) % | ||||
Current Valuation | 14.92 M | ||||
Shares Outstanding | 2.79 M | ||||
Shares Owned By Insiders | 70.00 % | ||||
Shares Owned By Institutions | 24.29 % | ||||
Number Of Shares Shorted | 17.63 K | ||||
Price To Earning | 11.16 X | ||||
Price To Book | 1.52 X | ||||
Price To Sales | 2.76 X | ||||
Revenue | 11.54 M | ||||
Gross Profit | (9.2 M) | ||||
EBITDA | (10.35 M) | ||||
Net Income | (10.58 M) | ||||
Cash And Equivalents | 36.61 M | ||||
Cash Per Share | 1.58 X | ||||
Total Debt | 1.31 M | ||||
Debt To Equity | 0.02 % | ||||
Current Ratio | 15.03 X | ||||
Book Value Per Share | 7.24 X | ||||
Cash Flow From Operations | (13.89 M) | ||||
Short Ratio | 2.69 X | ||||
Earnings Per Share | (5.13) X | ||||
Target Price | 4.0 | ||||
Number Of Employees | 34 | ||||
Beta | 1.1 | ||||
Market Capitalization | 33.46 M | ||||
Total Asset | 35.85 M | ||||
Retained Earnings | (230.88 M) | ||||
Working Capital | 26.01 M | ||||
Net Asset | 35.85 M |
About Sol Gel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sol Gel Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sol Gel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sol Gel Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Sol Gel Piotroski F Score and Sol Gel Altman Z Score analysis. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sol Gel. If investors know Sol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sol Gel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.13) | Revenue Per Share | Quarterly Revenue Growth 1.212 | Return On Assets | Return On Equity |
The market value of Sol Gel Technologies is measured differently than its book value, which is the value of Sol that is recorded on the company's balance sheet. Investors also form their own opinion of Sol Gel's value that differs from its market value or its book value, called intrinsic value, which is Sol Gel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sol Gel's market value can be influenced by many factors that don't directly affect Sol Gel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sol Gel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sol Gel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sol Gel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.